Finnrick, an independent testing programme, publishes 8 assays for Huatai Peptide: 2 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 6 did not. Most recent assay 30 Jul 2026.
Huatai Peptide operates from China, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/huatai-peptide.
Huatai Peptide sells direct to researchers and operates from China. It lists 73 products, including Retatrutide, Tirzepatide, Tesamorelin, BPC-157 + TB-500, MOTS-c, and Ipamorelin, plus 37 other compounds. It also produces and labels to order, so stock sold under other brand names may come from here.
In its own words: “Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy .”
Huatai Peptide publishes 4 certificates of analysis on its site, all credited to Janoshik Analytical. The vendor chose which batches to publish, so those results do not tell you what is in the vial you receive. Of the 12 product pages we opened, every one links its own certificate.
Prices run from $10.00 to $330.00 across 73 listed products. Payment is by cryptocurrency and bank transfer.
Worth knowing before you order: no card payments and no research-use-only notice. Payment is limited to cryptocurrency (USDT, USDC, BTC) and bank transfer. Neither route carries the chargeback protection a card payment gives you if an order never arrives or arrives wrong.
Site check: 73 products listed; 4 certificates of analysis published; payment by cryptocurrency, bank transfer; operates from China.
Huatai Peptide is listed as active. Finnrick Grade C. Finnrick avg score: 6.3/10 across 7 samples (1 products). Mixed quality — some products test well, others below average.
Huatai Peptide holds independent lab grade C, assigned across 7 graded samples, average score 6.3/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 8 | 2 passed, 6 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | C (7 samples) |
| Average grader score | 6.3/10 |
| Vendor type | Research-use supplier |
These details were read from Huatai Peptide's own website on 2026-08-10. Pages consulted:
Huatai Peptide is listed as active and we hold 8 Finnrick assays (2 passing, 6 failing its purity threshold); 4 certificates of analysis published on its own site; an independent lab grade of C. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 8 assays for Huatai Peptide: 2 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 6 did not. Most recent assay 30 Jul 2026.
Huatai Peptide accepts Cryptocurrency, Bank Transfer.
Huatai Peptide ships from China.
Similar vendors: Peptide Sciences, Limitless Life Nootropics, Polaris Peptides, NextechLabs, Yiwu Aozuo Trading Co, Shandong Shengyuan Peptide Technology, Bulk Peptide Supply, Skye Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Huayi Biotechnology Peptides Review, Hunan GoodPeptides Biotech Co Review, Hunan Ruiwang Technology Center Peptides Review.